VolitionRX Ltd. (VNRX)
1.37
-0.02
(-1.44%)
USD |
NYAM |
Jun 09, 14:16
VolitionRX SG&A Expense (Quarterly) : 3.482M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 294.36M |
| Neogen Corp. | 98.50M |
| QuidelOrtho Corp. | 199.30M |
| Aspira Women's Health, Inc. | 2.048M |
| Lucid Diagnostics, Inc. | 10.43M |